Reviews Ipol


No reviews yet.

Ipol Drug Description
IPOL®
Poliovirus Vaccine Inactivated
DRUG DESCRIPTION



What are the possible side effects of polio vaccine (Ipol)?

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with polio vaccine is much more dangerous to your health than receiving the vaccine to protect against it. Like any medicine, this vaccine can cause side effects, but the risk of serious...
Read All Potential Side Effects for Ipol »




IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is
a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2
(MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated
poliovirus vaccine with enhanced potency. Each of the three strains of poliovirus
is individually grown in vero cells, a continuous line of monkey kidney cells
cultivated on microcarriers.1,2 The cells are grown in Eagle MEM
modified medium, supplemented with newborn calf serum tested for adventitious
agents prior to use, originated from countries free of bovine spongiform encephalopathy.
For viral growth the culture medium is replaced by M-199, without calf serum.
This culture technique and improvements in purification, concentration and standardization
of poliovirus antigen produce a more potent and consistent immunogenic vaccine
than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.3,4
After clarification and filtration, viral suspensions are concentrated by ultrafiltration,
and purified by three liquid chromatography steps; one column of anion exchanger,
one column of gel filtration and again one column of anion exchanger. After
re-equilibration of the purified viral suspension, with Medium M-199 and adjustment
of the antigen titer, the monovalent viral suspensions are inactivated at +37°C
for at least 12 days with 1:4000 formalin.
Each dose (0.5 mL) of trivalent vaccine is formulated to contain 40 D antigen
units of Type 1, 8 D antigen units of Type 2, and 32 D antigen units of Type
3 poliovirus. For each lot of IPOL vaccine, D-antigen content is determined
in vitro using the D-antigen ELISA assay and immunogenicity is determined
by in vivo testing in animals. IPOL vaccine is produced from vaccine
concentrates diluted with M-199 medium. Also present are 0.5% of 2-phenoxyethanol
and a maximum of 0.02% of formaldehyde per dose as preservatives. Neomycin,
streptomycin and polymyxin B are used in vaccine production, and although purification
procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin
and 25 ng polymyxin B per dose may still be present. The residual calf serum
protein is less than 1 ppm in the final vaccine.
The vaccine is clear and colorless and should be administered intramuscularly
or subcutaneously.
REFERENCES
1. van Wezel AL, et al. Inactivated poliovirus vaccine: Current
production methods and new developments. Rev Infect Dis 6 (Suppl 2): S335-S340,
1984
2. Montagnon BJ, et al. Industrial scale production of inactivated
poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect
Dis 6 (Suppl 2): S341-S344, 1984
3. McBean AM, et al. Serologic response to oral polio vaccine
and enhanced-potency inactivated polio vaccines. Am J Epidemiol 128: 615-628,
1988
4. Murdin AD, et al. Inactivated poliovirus vaccine: past and
present experience. Vaccine 8: 735-746, 1996Last reviewed on RxList: 2/20/2009




Ipol Drug Description
IPOL®
Poliovirus Vaccine Inactivated
DRUG DESCRIPTION



What are the possible side effects of polio vaccine (Ipol)?

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with polio vaccine is much more dangerous to your health than receiving the vaccine to protect against it. Like any medicine, this vaccine can cause side effects, but the risk of serious...
Read All Potential Side Effects for Ipol »




IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is
a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2
(MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated
poliovirus vaccine with enhanced potency. Each of the three strains of poliovirus
is individually grown in vero cells, a continuous line of monkey kidney cells
cultivated on microcarriers.1,2 The cells are grown in Eagle MEM
modified medium, supplemented with newborn calf serum tested for adventitious
agents prior to use, originated from countries free of bovine spongiform encephalopathy.
For viral growth the culture medium is replaced by M-199, without calf serum.
This culture technique and improvements in purification, concentration and standardization
of poliovirus antigen produce a more potent and consistent immunogenic vaccine
than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.3,4
After clarification and filtration, viral suspensions are concentrated by ultrafiltration,
and purified by three liquid chromatography steps; one column of anion exchanger,
one column of gel filtration and again one column of anion exchanger. After
re-equilibration of the purified viral suspension, with Medium M-199 and adjustment
of the antigen titer, the monovalent viral suspensions are inactivated at +37°C
for at least 12 days with 1:4000 formalin.
Each dose (0.5 mL) of trivalent vaccine is formulated to contain 40 D antigen
units of Type 1, 8 D antigen units of Type 2, and 32 D antigen units of Type
3 poliovirus. For each lot of IPOL vaccine, D-antigen content is determined
in vitro using the D-antigen ELISA assay and immunogenicity is determined
by in vivo testing in animals. IPOL vaccine is produced from vaccine
concentrates diluted with M-199 medium. Also present are 0.5% of 2-phenoxyethanol
and a maximum of 0.02% of formaldehyde per dose as preservatives. Neomycin,
streptomycin and polymyxin B are used in vaccine production, and although purification
procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin
and 25 ng polymyxin B per dose may still be present. The residual calf serum
protein is less than 1 ppm in the final vaccine.
The vaccine is clear and colorless and should be administered intramuscularly
or subcutaneously.
REFERENCES
1. van Wezel AL, et al. Inactivated poliovirus vaccine: Current
production methods and new developments. Rev Infect Dis 6 (Suppl 2): S335-S340,
1984
2. Montagnon BJ, et al. Industrial scale production of inactivated
poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect
Dis 6 (Suppl 2): S341-S344, 1984
3. McBean AM, et al. Serologic response to oral polio vaccine
and enhanced-potency inactivated polio vaccines. Am J Epidemiol 128: 615-628,
1988
4. Murdin AD, et al. Inactivated poliovirus vaccine: past and
present experience. Vaccine 8: 735-746, 1996Last reviewed on RxList: 2/20/2009




Ipol Drug Description
IPOL®
Poliovirus Vaccine Inactivated
DRUG DESCRIPTION



What are the possible side effects of polio vaccine (Ipol)?

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with polio vaccine is much more dangerous to your health than receiving the vaccine to protect against it. Like any medicine, this vaccine can cause side effects, but the risk of serious...
Read All Potential Side Effects for Ipol »




IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is
a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2
(MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated
poliovirus vaccine with enhanced potency. Each of the three strains of poliovirus
is individually grown in vero cells, a continuous line of monkey kidney cells
cultivated on microcarriers.1,2 The cells are grown in Eagle MEM
modified medium, supplemented with newborn calf serum tested for adventitious
agents prior to use, originated from countries free of bovine spongiform encephalopathy.
For viral growth the culture medium is replaced by M-199, without calf serum.
This culture technique and improvements in purification, concentration and standardization
of poliovirus antigen produce a more potent and consistent immunogenic vaccine
than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.3,4
After clarification and filtration, viral suspensions are concentrated by ultrafiltration,
and purified by three liquid chromatography steps; one column of anion exchanger,
one column of gel filtration and again one column of anion exchanger. After
re-equilibration of the purified viral suspension, with Medium M-199 and adjustment
of the antigen titer, the monovalent viral suspensions are inactivated at +37°C
for at least 12 days with 1:4000 formalin.
Each dose (0.5 mL) of trivalent vaccine is formulated to contain 40 D antigen
units of Type 1, 8 D antigen units of Type 2, and 32 D antigen units of Type
3 poliovirus. For each lot of IPOL vaccine, D-antigen content is determined
in vitro using the D-antigen ELISA assay and immunogenicity is determined
by in vivo testing in animals. IPOL vaccine is produced from vaccine
concentrates diluted with M-199 medium. Also present are 0.5% of 2-phenoxyethanol
and a maximum of 0.02% of formaldehyde per dose as preservatives. Neomycin,
streptomycin and polymyxin B are used in vaccine production, and although purification
procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin
and 25 ng polymyxin B per dose may still be present. The residual calf serum
protein is less than 1 ppm in the final vaccine.
The vaccine is clear and colorless and should be administered intramuscularly
or subcutaneously.
REFERENCES
1. van Wezel AL, et al. Inactivated poliovirus vaccine: Current
production methods and new developments. Rev Infect Dis 6 (Suppl 2): S335-S340,
1984
2. Montagnon BJ, et al. Industrial scale production of inactivated
poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect
Dis 6 (Suppl 2): S341-S344, 1984
3. McBean AM, et al. Serologic response to oral polio vaccine
and enhanced-potency inactivated polio vaccines. Am J Epidemiol 128: 615-628,
1988
4. Murdin AD, et al. Inactivated poliovirus vaccine: past and
present experience. Vaccine 8: 735-746, 1996Last reviewed on RxList: 2/20/2009




Ipol Drug Description
IPOL®
Poliovirus Vaccine Inactivated
DRUG DESCRIPTION



What are the possible side effects of polio vaccine (Ipol)?

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with polio vaccine is much more dangerous to your health than receiving the vaccine to protect against it. Like any medicine, this vaccine can cause side effects, but the risk of serious...
Read All Potential Side Effects for Ipol »




IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is
a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2
(MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated
poliovirus vaccine with enhanced potency. Each of the three strains of poliovirus
is individually grown in vero cells, a continuous line of monkey kidney cells
cultivated on microcarriers.1,2 The cells are grown in Eagle MEM
modified medium, supplemented with newborn calf serum tested for adventitious
agents prior to use, originated from countries free of bovine spongiform encephalopathy.
For viral growth the culture medium is replaced by M-199, without calf serum.
This culture technique and improvements in purification, concentration and standardization
of poliovirus antigen produce a more potent and consistent immunogenic vaccine
than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.3,4
After clarification and filtration, viral suspensions are concentrated by ultrafiltration,
and purified by three liquid chromatography steps; one column of anion exchanger,
one column of gel filtration and again one column of anion exchanger. After
re-equilibration of the purified viral suspension, with Medium M-199 and adjustment
of the antigen titer, the monovalent viral suspensions are inactivated at +37°C
for at least 12 days with 1:4000 formalin.
Each dose (0.5 mL) of trivalent vaccine is formulated to contain 40 D antigen
units of Type 1, 8 D antigen units of Type 2, and 32 D antigen units of Type
3 poliovirus. For each lot of IPOL vaccine, D-antigen content is determined
in vitro using the D-antigen ELISA assay and immunogenicity is determined
by in vivo testing in animals. IPOL vaccine is produced from vaccine
concentrates diluted with M-199 medium. Also present are 0.5% of 2-phenoxyethanol
and a maximum of 0.02% of formaldehyde per dose as preservatives. Neomycin,
streptomycin and polymyxin B are used in vaccine production, and although purification
procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin
and 25 ng polymyxin B per dose may still be present. The residual calf serum
protein is less than 1 ppm in the final vaccine.
The vaccine is clear and colorless and should be administered intramuscularly
or subcutaneously.
REFERENCES
1. van Wezel AL, et al. Inactivated poliovirus vaccine: Current
production methods and new developments. Rev Infect Dis 6 (Suppl 2): S335-S340,
1984
2. Montagnon BJ, et al. Industrial scale production of inactivated
poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect
Dis 6 (Suppl 2): S341-S344, 1984
3. McBean AM, et al. Serologic response to oral polio vaccine
and enhanced-potency inactivated polio vaccines. Am J Epidemiol 128: 615-628,
1988
4. Murdin AD, et al. Inactivated poliovirus vaccine: past and
present experience. Vaccine 8: 735-746, 1996Last reviewed on RxList: 2/20/2009




Ipol Drug Description
IPOL®
Poliovirus Vaccine Inactivated
DRUG DESCRIPTION



What are the possible side effects of polio vaccine (Ipol)?

You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with polio vaccine is much more dangerous to your health than receiving the vaccine to protect against it. Like any medicine, this vaccine can cause side effects, but the risk of serious...
Read All Potential Side Effects for Ipol »




IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is
a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2
(MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated
poliovirus vaccine with enhanced potency. Each of the three strains of poliovirus
is individually grown in vero cells, a continuous line of monkey kidney cells
cultivated on microcarriers.1,2 The cells are grown in Eagle MEM
modified medium, supplemented with newborn calf serum tested for adventitious
agents prior to use, originated from countries free of bovine spongiform encephalopathy.
For viral growth the culture medium is replaced by M-199, without calf serum.
This culture technique and improvements in purification, concentration and standardization
of poliovirus antigen produce a more potent and consistent immunogenic vaccine
than the inactivated poliovirus vaccine (IPV) available in the US prior to 1988.3,4
After clarification and filtration, viral suspensions are concentrated by ultrafiltration,
and purified by three liquid chromatography steps; one column of anion exchanger,
one column of gel filtration and again one column of anion exchanger. After
re-equilibration of the purified viral suspension, with Medium M-199 and adjustment
of the antigen titer, the monovalent viral suspensions are inactivated at +37°C
for at least 12 days with 1:4000 formalin.
Each dose (0.5 mL) of trivalent vaccine is formulated to contain 40 D antigen
units of Type 1, 8 D antigen units of Type 2, and 32 D antigen units of Type
3 poliovirus. For each lot of IPOL vaccine, D-antigen content is determined
in vitro using the D-antigen ELISA assay and immunogenicity is determined
by in vivo testing in animals. IPOL vaccine is produced from vaccine
concentrates diluted with M-199 medium. Also present are 0.5% of 2-phenoxyethanol
and a maximum of 0.02% of formaldehyde per dose as preservatives. Neomycin,
streptomycin and polymyxin B are used in vaccine production, and although purification
procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin
and 25 ng polymyxin B per dose may still be present. The residual calf serum
protein is less than 1 ppm in the final vaccine.
The vaccine is clear and colorless and should be administered intramuscularly
or subcutaneously.
REFERENCES
1. van Wezel AL, et al. Inactivated poliovirus vaccine: Current
production methods and new developments. Rev Infect Dis 6 (Suppl 2): S335-S340,
1984
2. Montagnon BJ, et al. Industrial scale production of inactivated
poliovirus vaccine prepared by culture of Vero cells on microcarrier. Rev Infect
Dis 6 (Suppl 2): S341-S344, 1984
3. McBean AM, et al. Serologic response to oral polio vaccine
and enhanced-potency inactivated polio vaccines. Am J Epidemiol 128: 615-628,
1988
4. Murdin AD, et al. Inactivated poliovirus vaccine: past and
present experience. Vaccine 8: 735-746, 1996Last reviewed on RxList: 2/20/2009





Other reviews about Ipol on wordpress

How to Get the Look: Black Headbands
  by StyleWatch
Evening updos can be daunting to most women, and many red carpet updos seem impossible to do on your own (no wonder Jessica Simpson is best friends with […]


Do Ya' Think?
  by Doug Krile
This says tons about what's wrong with televised debates these days.  They've become showcases for the network "talent", not true displays of candidates' knowledge...Wolf Blitzer gets more talking […]


Charlize Theron's Big Give: Bid on Her Cannes Festival Gown!
  by StyleWatch
IPOL/Globe First Drew Barrymore donated $1 million dollars while on The Oprah Winfrey Show, and now Charlize Theron is appearing today to donate her one-of-a-kind Narciso […]


vaccines do not cause autism. autism causes autism.
  by feebeeglee
I am 100% sure that Bede's autism was not caused by vaccines. Because he hasn't had any. I don't think vaccines cause autism. I could believe that they […]


Winter 2009 Schedule
  by racheleanore
502 - Network Computing510 - Data Security and Privacy620 - Collection Development and Management643 - Professional Practice in Libraries and Information CentersI've decided to attempt a second specialization […]


In Which I Grouse About the USPS
  by Sarah
How can the POST OFFICE be OUT of STAMPS? No, really. They're out of stamps. This is the conversation I had. (Curtain. Middle of Williamsburg post office. Transaction nearing completion. […]


IPOL Speaker Series starts with One Web Day
  by Michael Perry
Mark your calendars! IPOL will be sponsoring a Speakers Series event on September 22 (11:30 - 1 p.m.) in the Ehrlicher Room. The event coincides with One Web […]


IPOL announces student paper competition
  by Jay Jackson
Assistant Professor Steven Jackson has announced the first Information Policy Student Paper Competition at the School of Informaiton. This competition gives students the opportunity to develop policy research […]


Know Thyself
  by Allister Timms
Here is a list of “I” things I could really use: An iStick. A device to beat me into work mode. An iLips. Says the things everybody wants to hear. An […]



Other reviews about Ipol on web:

tallit,kipot,tefilin,shofars,mezuzot,Shabat and Holiday objects,arts and crafts,home accessories,stationery,jewelry. Gifts for Bar/Bat mitzvah,weddings Image Plus On-Line


Learn about the prescription medication Ipol (Poliovirus Vaccine Inactivated), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ipol (Poliovirus Vaccine Inactivated) Drug Information: Uses, Side ...


iPol: [EYE-pawl] - n. pseudo-English idiom ~ the Personal Pronoun, as applied to politics iPol


All about Ipol. View complete and up to date Ipol information - part of the Drugs.com trusted medication database. Ipol Facts and Comparisons at Drugs.com


Accurate, FDA approved IPOL information for healthcare professionals and patients - brought to you by Drugs.com. IPOL Official FDA information, side effects and uses.


IPOL is simply the most cost effective way to file a trade mark application online in New Zealand. Using the Wizard, you write and file the application yourself for as little as $ ... IPOL : The simple, cost effective way to file Trade Mark and ...


Vaccination with IPOL vaccine may not protect all individuals. For more information about IPOL vaccine, talk to your health-care professional. Polio Disease


IPOL is an injectable vaccine often given during childhood to prevent polio. This article from the eMedTV Web site describes how this vaccination works, explains when and how to ... IPOL


IPOL publishes relevant image processing and image analysis algorithms: description, implementation, demonstration, discussion. Open Source, Open Access. IPOL: Image Processing On Line


IPOL can be contacted via electronic and postal mail IPOL: Contact Us





Featured Reviews

Reviews Perindopril Erbumine

Aceon Drug Description ACEON® (perindopril erbumine) Tablets USE IN PREGNANCY When used in pregnancy, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, ACEON® Tablets...
Read More  |  Review This
Reviews Dianeal PD-1

Dianeal PD-1 Drug Description DIANEAL PD-1 (peritoneal) Dialysis Solution AMBU-FLEX III Container For Peritoneal Dialysis For intraperitoneal administration only DRUG DESCRIPTION DIANEAL PD-1 peritoneal dialysis solutions in AMBU-FLEX...
Read More  |  Review This
Reviews Zavesca

Zavesca Drug Description Zavesca® (miglustat) Capsules, 100mg DRUG DESCRIPTION What are the possible side effects of miglustat (Zavesca)? Nerve problems such as numbness, tingling, and tremor (shaking) of the hands have been...
Read More  |  Review This
Reviews Indocin

Indocin Drug Description INDOCIN® (indomethacin) Capsules, Suppositories Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be...
Read More  |  Review This
Reviews Saizen

Saizen Drug Description Saizen® [somatropin (rDNA origin) for injection] For subcutaneous or intramuscular injection DRUG DESCRIPTION Saizen® [somatropin (rDNA origin) for injection] is a human growth hormone produced by recombinant...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....